It was observed that CD8+ and CD20+ immunogradient indicators, that reflect cell migration towards the tumor, were associated with improved patient survival, while the infiltrative tumor growth pattern was linked to worse patient outcomes. The gene discussed is CD8A; the disease is neoplasm.